Nonclinical factors are more likely to drive discontinuation of biologic therapy for patients with severe asthma.
Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results